Published in Perfusion on March 01, 2008
Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDS. Eur J Med Res (2012) 0.94
Defining the late implementation of extracorporeal membrane oxygenation (ECMO) by identifying increased mortality risk using specific physiologic cut-points in neonatal and pediatric respiratory patients. J Extra Corpor Technol (2009) 0.81
Magnitude of arterial carbon dioxide change at initiation of extracorporeal membrane oxygenation support is associated with survival. J Extra Corpor Technol (2013) 0.75
Extracorporeal membrane oxygenation in acute respiratory distress syndrome due to influenza A (H1N1)pdm09 pneumonia. A single-center experience during the 2013-2014 season. Rev Bras Ter Intensiva (2017) 0.75
Lumbar spinal stenosis: conservative or surgical management?: A prospective 10-year study. Spine (Phila Pa 1976) (2000) 3.69
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg (2006) 2.74
Lumbar spinal stenosis. Clinical and radiologic features. Spine (Phila Pa 1976) (1995) 2.37
Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg (1993) 2.25
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Follow-up and final results of the Oslo I Study comparing screen-film mammography and full-field digital mammography with soft-copy reading. Acta Radiol (2005) 2.16
The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE. J Intern Med (2007) 2.07
Thrombolytic therapy for acute myocardial infarction in older patients. Lancet (1996) 2.03
Sternal wound infections in patients undergoing open heart surgery: randomized study comparing intracutaneous and transcutaneous suture techniques. Ann Thorac Surg (2001) 2.00
Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin) Thromb Haemost (1997) 1.73
Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62
Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer (1984) 1.52
Extracorporeal membrane oxygenation using a centrifugal pump and a servo regulator to prevent negative inlet pressure. Ann Thorac Surg (1997) 1.50
Viral safety of solvent/detergent-treated plasma. Transfusion (2000) 1.46
Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study. J Thromb Haemost (2005) 1.45
Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study. Eur Heart J (1996) 1.41
Mechanical valve replacement in congenital heart disease. J Heart Valve Dis (1996) 1.40
Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand (1995) 1.39
Content and distribution of macrophages and lymphocytes in solid malignant human tumours. Int J Cancer (1979) 1.17
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol (1996) 1.15
Transportation of critically ill patients on extracorporeal membrane oxygenation. Perfusion (2008) 1.11
Association between intraoperative cerebral microembolic signals and postoperative neuropsychological deficit: comparison between patients with cardiac valve replacement and patients with coronary artery bypass grafting. J Neurol Neurosurg Psychiatry (1998) 1.05
Risk factors in primary sclerosing cholangitis. J Hepatol (1994) 1.04
Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg (1998) 1.00
Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost (1994) 1.00
In situ analysis of the inflammatory cell infiltrates in colon carcinomas and in the normal colon wall. Acta Pathol Microbiol Immunol Scand A (1982) 0.99
Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population. J Thorac Cardiovasc Surg (1999) 0.99
Cerebral microembolic signals during cardiopulmonary bypass surgery. Frequency, time of occurrence, and association with patient and surgical characteristics. Stroke (1997) 0.98
Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thorac Cardiovasc Surg (1996) 0.98
Isolation and characterization of lymphocytes and macrophages from solid, malignant human tumours. Int J Cancer (1979) 0.98
Carcinoma arising in a lung cyst. Scand J Thorac Cardiovasc Surg (1979) 0.94
Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion (2007) 0.94
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury (1998) 0.91
Carcinoma of the stomach. A ten-year material. Acta Chir Scand (1976) 0.91
Health-related quality of life in narcolepsy. Acta Neurol Scand (2006) 0.90
The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism. Br J Haematol (2006) 0.89
Graft control by transit time flow measurement and intraoperative angiography in coronary artery bypass surgery. Heart Surg Forum (2001) 0.89
Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg (1992) 0.87
Effects of long-term anticoagulant therapy in subgroups after acute myocardial infarction. Arch Intern Med (1992) 0.86
Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg (1995) 0.86
The CarboMedics valve: midterm follow-up with analysis of risk factors. Ann Thorac Surg (1995) 0.86
Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation (1995) 0.85
Vascular complications of the intraaortic balloon pump in patients undergoing open heart operations: 15-year experience. Ann Thorac Surg (1999) 0.85
Up to eight years' follow-up of 997 patients receiving the CarboMedics prosthetic heart valve. Ann Thorac Surg (1998) 0.85
D-dimer level is associated with the extent of pulmonary embolism. Thromb Res (2006) 0.85
Long-term effects of n-3 fatty acids on serum lipids and glycaemic control. Scand J Clin Lab Invest (1994) 0.83
Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism (1995) 0.83
Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand (1999) 0.83
Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol (2000) 0.83
Birth weight and melanoma risk: a population-based case-control study. Br J Cancer (2007) 0.83
Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion (1999) 0.83
Extracorporeal membrane oxygenation support for 59 days without changing the ECMO circuit: a case of Legionella pneumonia. Perfusion (2009) 0.83
Transthoracic intra-aortic balloon pump in open heart operations: techniques and outcome. Scand Cardiovasc J (2001) 0.83
Risk factors associated with mortality and morbidity after elective splenectomy. Eur J Surg (1995) 0.82
Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations. Ann Thorac Surg (1991) 0.82
Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion (1998) 0.82
Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study. Eur J Cardiothorac Surg (1997) 0.82
N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol (1999) 0.82
Time for new concepts about measurement of complement activation by cardiopulmonary bypass? Ann Thorac Surg (1992) 0.81
Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects. Ann Thorac Surg (1995) 0.81
Intraoperative angiography in minimally invasive direct coronary artery bypass grafting. Ann Thorac Surg (1997) 0.81
Parental consanguinity is associated with a seven-fold increased risk of progressive encephalopathy: a cohort study from Oslo, Norway. Eur J Paediatr Neurol (2009) 0.81
[Triage. Initial diagnosis of life-threatening injuries based on functional state and mechanism of injury]. Tidsskr Nor Laegeforen (1990) 0.81
Duration of preoperative electrocardiographic QRS complex and the incidence of heart arrest after aorto coronary bypass surgery. Scand Cardiovasc J (2000) 0.81
Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables. Scand Cardiovasc J (2001) 0.80
Cells bearing Fc receptors in human malignant solid tumours. Br J Cancer (1982) 0.80
Coarctation of the aorta, early and late results of various surgical techniques. J Cardiovasc Surg (Torino) (1990) 0.80
Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo. J Thorac Cardiovasc Surg (1999) 0.80
Hemodynamic effects of intraaortic versus intravenous protamine administration after cardiopulmonary bypass in man. Scand J Thorac Cardiovasc Surg (1992) 0.80
Pulsatile vs. non-pulsatile flow during cardiopulmonary bypass. A comparison of early postoperative changes. Scand J Thorac Cardiovasc Surg (1984) 0.80
T lymphocytes in malignant, non-lymphoid human tumours detected by esterase technique. Scand J Immunol (1980) 0.80
Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis. Eur J Cardiothorac Surg (1996) 0.80
Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs (1991) 0.79
Coronary artery bypass surgery in women and in men; early and long-term results. A study of the Norwegian population adjusted by age and sex. Eur J Cardiothorac Surg (1997) 0.79
Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70. Eur Surg Res (1988) 0.79
Characterization of lymphocytes isolated from non-lymphoid human malignant tumours. Scand J Immunol (1978) 0.79
Course guidelines for minimally invasive cardiac surgery. STS/AATS Ad Hoc Committee on New Technology Assessment. American Association for Thoracic Surgery. J Thorac Cardiovasc Surg (1998) 0.79
Long term morbidity and mortality after kidney transplantation. Scand J Urol Nephrol (1992) 0.79
Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg (2000) 0.79
Prevalence of narcolepsy with cataplexy in Norway. Acta Neurol Scand (2009) 0.79
Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol (1990) 0.79
Pancreaticobiliary diseases. Comparison of 2D single-shot turbo spin-echo MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Acta Radiol (2000) 0.78
Corticosteroids in the treatment of blunt injury of the chest. Injury (1984) 0.78
Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg (1991) 0.78
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting. Am J Cardiol (1994) 0.78
Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation. Scand J Clin Lab Invest (1995) 0.78
Cell markers in stored blood. Injury (1985) 0.78
Complement activation with bubble and membrane oxygenators in aortocoronary bypass grafting. Ann Thorac Surg (1990) 0.78